$ATI

Fields Kimberly A sold $548K of ATI

Fields Kimberly A (Chair, President and CEO) sold 3,001 shares of ATI INC (ATI) at $182.75 ($0.55M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fields Kimberly A
Published Jun 4, 2026, 11:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 11:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATI
Neutral
medium confidence
Mentioned
$ATI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATINeutralLow
01

Why it matters

Provides a concrete datapoint on executive share sales but no accompanying operational or financial catalyst.

02

Market read

Traders may monitor for follow-on insider activity, but this specific filing alone is unlikely to reset valuation expectations.

03

What to watch

Insider sales can be driven by diversification/tax planning; without changes in buying/selling patterns or accompanying fundamentals, inference is limited.

Relevance 6/10Novelty 4/10Timing: Filed today; sale executed 2026-06-02

Background

The article is an SEC Form 4 insider transaction disclosure for ATI, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$ATINeutralMedium confidence
Context

SEC Form 4 shows ATI CEO/Chair Kimberly A. Fields sold 3,001 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Near-term price impact likely minimal; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing provides a specific sale size and price but does not indicate a new company event (earnings, guidance, deal, litigation). 10b5-1 plans typically reduce interpretive weight.

Market effects

No clear sector read-through; this is a single-company insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

If the market overreacts to the headline, the 10b5-1 designation suggests the sale may be routine rather than a bearish signal.

Key entities

  • ATI INC

    Subject of the Form 4 insider transaction; CEO/Chair Kimberly A. Fields sold shares under a 10b5-1 plan.

  • Kimberly A. Fields

    Chair, President and CEO; reported open-market sale of 3,001 shares at $182.75 on 2026-06-02.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATIMed

How Investors Are Reacting To ATI (ATI) Record Backlog And Raised Guidance

ATI Inc. raised its 2026 adjusted EBITDA and free cash flow guidance, citing record backlog and strong aerospace and defense demand. The company's updated outlook includes high teens defense growth, reinforcing its long-cycle thesis. ATI's share price is up 64% year-to-date, outpacing its industry group. Key risks include execution challenges and softer demand in industrial and medical sectors.

$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.